Skip to main content

Table 2 Concentrations of the cholesterol subfractions measured by Lipoprint in MS patients and controls. Data are expressed as mean ± SD, in case of non-parametric distribution as median (25th - 75th percentile)

From: Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?

 

MS (n = 19)

Controls (n = 19)

VLDL (mmol/l)

0.757 ± 0.328

0.595 (0.524–0.847)

IDL-A (mmol/l)

0.218 ± 0.105

0.216 ± 0.086

IDL-B (mmol/l)

0.259 (0.207–0.310)

0.233 (0.181–0.284)

IDL-C (mmol/l)

0.885 ± 0.243

0.834 ± 0.198

LDL1 (mmol/l)

0.361 ± 0.273

0.404 ± 0.230

LDL2 (mmol/l)

0.207 (0.000–0.259)

0.200 ± 0.217

LDL3–7 (mmol/l)

0.000 (0.000–0.052)

0.000 (0.000–0.039)

Large HDL (mmol/l)

0.763 (0.595–0.957)

0.709 ± 0.271

Intermediate HDL (mmol/l)

0.646 (0.543–0.802)

0.621 ± 0.113

Small HDL (mmol/l)

0.111 ± 0.085

0.090 ± 0.072

Total cholesterol (mmol/l)

4.54 ± 0.95

4.07 ± 0.73